ICD-10-CM Code D46.21

Valid for Submission

D46.21 is a billable code used to specify a medical diagnosis of refractory anemia with excess of blasts 1. The code is valid for the fiscal year 2021 for the submission of HIPAA-covered transactions. The ICD-10-CM code D46.21 might also be used to specify conditions or terms like refractory anemia with excess blasts or refractory anemia with excess blasts-1.

Tabular List of Diseases and Injuries

The Tabular List of Diseases and Injuries is a list of ICD-10 codes, organized "head to toe" into chapters and sections with guidance for inclusions, exclusions, descriptions and more. The following references are applicable to the code D46.21:

Inclusion Terms

Inclusion Terms
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.

• RAEB 1

Index to Diseases and Injuries

The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code D46.21 are found in the index:

• - Anemia (essential) (general) (hemoglobin deficiency) (infantile) (primary) (profound) - D64.9
  • - refractory - D46.4
    • - with
      • - excess of blasts - D46.20
        • - 1 (RAEB 1) - D46.21

Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

• Refractory anemia with excess blasts
• Refractory anemia with excess blasts-1

Diagnostic Related Groups

The ICD-10 code D46.21 is grouped in the following groups for version MS-DRG V38.0 What are Diagnostic Related Groups?
The Diagnostic Related Groups (DRGs) are a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC). applicable from 10/01/2020 through 09/30/2021.

• 811 - RED BLOOD CELL DISORDERS WITH MCC
• 812 - RED BLOOD CELL DISORDERS WITHOUT MCC

Convert D46.21 to ICD-9

• 238.72 - Low grde myelody syn les (Approximate Flag)

Code Classification

• Neoplasms (C00–D48)
  • Neoplasms of uncertain behavior, polycythemia vera and myelodysplastic syndromes (D37-D48)
    • Myelodysplastic syndromes (D46)

Code History

• FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016
  (First year ICD-10-CM implemented into the HIPAA code set)
• FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
• FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
• FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
• FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
• FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021

Tools

• Copy Code
• Copy Description
• View Related Codes
• Convert D46.21 to ICD-9